NASDAQ

4D Molecular Therapeutics, Inc. (FDMT)

♥ 604 Thanks from members

Live price chart, market sentiment, and community perspectives for 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: David SchafferLeadership: David Schaffer (CEO)Holder: Perceptive AdvisorsHolder: RA Capital ManagementHolder: Vanguard Group4D-125 for Retinitis Pigmentosa4D-150 for Wet AMDAAV Gene Delivery Platform#4D Molecular Therapeutics#FDMT Stock#Gene Therapy#Biotech#AAV Vectors